UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 18, 2015
SIGMA-ALDRICH CORPORATION
(Exact name of Registrant as specified in its charter)
| Delaware | 43-1050617 | |
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |
3050 Spruce Street
St. Louis, Missouri 63103
(314) 771-5765
(Address of Principal Executive Offices including Zip Code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| Item 2.01 | Completion of Acquisition or Disposition of Assets. |
On November 18, 2015, Merck KGaA (“Merck”) completed its acquisition of Sigma-Aldrich Corporation (“Sigma”). As a result, Sigma is now an indirect, wholly-owned subsidiary of Merck.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| SIGMA-ALDRICH CORPORATION | ||||||
| Dated: November 18, 2015 | By: | /s/ Udit Batra | ||||
| Name: | Udit Batra | |||||
| Title: | Director and Chief Executive Officer | |||||
